Targeting myocardial beta-adrenergic receptor signaling and calcium cycling for heart failure gene therapy.
about
Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal modelS100A1 in cardiovascular health and disease: closing the gap between basic science and clinical therapyS100A1: Structure, Function, and Therapeutic PotentialS100A1: a multifaceted therapeutic target in cardiovascular diseaseBasal and β-adrenergic regulation of the cardiac calcium channel CaV1.2 requires phosphorylation of serine 1700Protective Role for LPA3 in Cardiac Hypertrophy Induced by Myocardial Infarction but Not by Isoproterenol.G alpha(q)-mediated activation of GRK2 by mechanical stretch in cardiac myocytes: the role of protein kinase C.Reversal of impaired myocardial beta-adrenergic receptor signaling by continuous-flow left ventricular assist device support.Level of G protein-coupled receptor kinase-2 determines myocardial ischemia/reperfusion injury via pro- and anti-apoptotic mechanisms.Palmitoylation regulates intracellular trafficking of β2 adrenergic receptor/arrestin/phosphodiesterase 4D complexes in cardiomyocytes.G protein-coupled receptor kinase-2 is a novel regulator of collagen synthesis in adult human cardiac fibroblasts.Enhanced cardiac function in Gravin mutant mice involves alterations in the β-adrenergic receptor signaling cascadeG protein coupled receptor kinases as therapeutic targets in cardiovascular disease.Altered β-adrenergic response in mice lacking myotonic dystrophy protein kinaseA pharmacokinetic analysis of molecular cardiac surgery with recirculation mediated delivery of βARKct gene therapy: developing a quantitative definition of the therapeutic window.Compartmentalization of beta-adrenergic signals in cardiomyocytes.Myocardial repair: from salvage to tissue reconstruction.Sarcomere length dependence of power output is increased after PKA treatment in rat cardiac myocytesDesigning heart performance by gene transfer.Bitransgenesis with beta(2)-adrenergic receptors or adenylyl cyclase fails to improve beta(1)-adrenergic receptor cardiomyopathy.Targeted gene therapy for the treatment of heart failure.Cardiac gene therapy in large animals: bridge from bench to bedside.Cardiomyocytes, endothelial cells and cardiac fibroblasts: S100A1's triple action in cardiovascular pathophysiology.Therapeutic safety of high myocardial expression levels of the molecular inotrope S100A1 in a preclinical heart failure model.Role of β-blocker therapy in pediatric heart failureReduced effects of BAY K 8644 on L-type Ca2+ current in failing human cardiac myocytes are related to abnormal adrenergic regulation.Rescuing a failing heart: putting on the squeeze.The role of β-adrenergic receptors and p38MAPK signaling pathways in physiological processes of cardiosphere-derived cells.
P2860
Q28243737-23CC8365-BD85-4033-90CD-5B9CCB31C561Q28249115-1A8702AD-9F5C-43B7-A9B8-BCB97C8A7F3BQ28263662-E0EB2509-CFA3-4012-B22A-557BBF2A2F9EQ28288362-C0987521-CFF2-40FE-A022-D09242210DD8Q30602522-AA2D4314-28E7-40C4-861F-4BA82DF1A13CQ33736651-E893EBDB-3BD4-4C9B-A157-25D811C44C9AQ33810086-C8E79B8B-8528-45EE-B95B-B8BBEEA9EB05Q33876021-0D3374A5-9126-44DA-8B29-5829DA555E99Q34253155-7CE2EA47-F583-4D35-A0E1-5D8BD48952B0Q34388807-A162F8A4-3907-437A-976C-8675B3C89911Q34869712-7EB28F6E-216A-4C4F-9DCA-D4A6692F3B52Q34994899-CE5E8171-2FA6-471F-B764-68FA84B8CE08Q35135090-2FD33D2B-AE5A-4FC2-B0DF-2D438F0DBE59Q36174612-8B2B78A0-CE8A-4511-A3C6-D326BD9D52C5Q36185039-7C7FA55C-A0F5-4B49-8828-694F0EE5C44CQ36384788-1F1A024B-8A9F-4306-BEFB-36E788DBBCBDQ37176440-DAABFD7D-B8F2-42CF-BA36-B33BA9071FC9Q37200169-D3A9AF30-F662-44C7-8CCC-345EDFB75E82Q37299072-A8DB801A-D51C-4B4B-BD11-CBC1C1C4FE2FQ37700355-98448774-1C55-4AA0-AE39-160DB6C841ADQ37878086-5B001F6D-6AAF-472E-9C38-E10A8288FB8FQ37981008-CA573E6D-E183-4F07-B0AB-99C87F1BFBE4Q38506250-8456354F-1940-46D1-9BE2-62C8D486C839Q41890749-3CE3684C-DF43-4328-ACC6-37EB10B063CFQ42034500-0AB88494-F9FD-488E-BAF7-5239999AAFB5Q42248990-887BC6B4-58F5-41F1-B728-68F0E6AF302BQ44389489-4F456653-D71B-4178-9C68-5B3291C95780Q48103647-50ABFCF5-B9EE-4F84-A3DE-72C98B7EE1CE
P2860
Targeting myocardial beta-adrenergic receptor signaling and calcium cycling for heart failure gene therapy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Targeting myocardial beta-adre ...... or heart failure gene therapy.
@en
type
label
Targeting myocardial beta-adre ...... or heart failure gene therapy.
@en
prefLabel
Targeting myocardial beta-adre ...... or heart failure gene therapy.
@en
P2093
P1476
Targeting myocardial beta-adre ...... or heart failure gene therapy.
@en
P2093
Matthieu Boucher
Patrick Most
Sven T Pleger
Walter J Koch
P304
P356
10.1016/J.CARDFAIL.2007.01.003
P577
2007-06-01T00:00:00Z